Zacks Research Lifts Earnings Estimates for ProAssurance

ProAssurance Co. (NYSE:PRA) – Stock analysts at Zacks Research upped their Q3 2025 earnings estimates for ProAssurance in a research note issued on Thursday, March 13th. Zacks Research analyst K. Dey now expects that the insurance provider will post earnings per share of $0.28 for the quarter, up from their prior forecast of $0.23. The consensus estimate for ProAssurance’s current full-year earnings is $0.80 per share. Zacks Research also issued estimates for ProAssurance’s Q4 2025 earnings at $0.24 EPS, FY2025 earnings at $0.91 EPS, Q1 2026 earnings at $0.22 EPS, Q2 2026 earnings at $0.25 EPS, Q3 2026 earnings at $0.29 EPS, Q4 2026 earnings at $0.30 EPS, FY2026 earnings at $1.06 EPS and FY2027 earnings at $1.17 EPS.

ProAssurance (NYSE:PRA) last announced its quarterly earnings results on Monday, February 24th. The insurance provider reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.19. The company had revenue of $287.52 million for the quarter, compared to analysts’ expectations of $274.56 million. ProAssurance had a net margin of 3.71% and a return on equity of 2.65%.

Separately, StockNews.com upgraded shares of ProAssurance from a “hold” rating to a “buy” rating in a research note on Thursday, March 6th.

ProAssurance Trading Up 0.1 %

Shares of NYSE:PRA opened at $15.73 on Monday. The stock has a market capitalization of $804.75 million, a PE ratio of 18.95 and a beta of 0.21. The company’s 50-day moving average price is $15.06 and its two-hundred day moving average price is $15.27. ProAssurance has a one year low of $10.76 and a one year high of $17.79. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.28 and a quick ratio of 0.28.

Hedge Funds Weigh In On ProAssurance

Several institutional investors and hedge funds have recently added to or reduced their stakes in PRA. Mariner LLC increased its position in shares of ProAssurance by 4.2% during the fourth quarter. Mariner LLC now owns 17,007 shares of the insurance provider’s stock worth $271,000 after buying an additional 688 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of ProAssurance by 4.0% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 28,991 shares of the insurance provider’s stock valued at $461,000 after purchasing an additional 1,127 shares in the last quarter. Rhumbline Advisers lifted its position in shares of ProAssurance by 0.8% during the fourth quarter. Rhumbline Advisers now owns 160,707 shares of the insurance provider’s stock valued at $2,557,000 after purchasing an additional 1,281 shares in the last quarter. Sterling Capital Management LLC lifted its position in shares of ProAssurance by 859.4% during the fourth quarter. Sterling Capital Management LLC now owns 1,631 shares of the insurance provider’s stock valued at $26,000 after purchasing an additional 1,461 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. lifted its position in shares of ProAssurance by 0.3% during the third quarter. Jacobs Levy Equity Management Inc. now owns 587,901 shares of the insurance provider’s stock valued at $8,842,000 after purchasing an additional 1,738 shares in the last quarter. 85.58% of the stock is currently owned by institutional investors and hedge funds.

About ProAssurance

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.